Raymond James & Associates’s CorMedix CRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$387K Sell
47,837
-1,995
-4% -$10.8K ﹤0.01% 3257
2024
Q2
$216K Buy
49,832
+4,005
+9% +$20.3K ﹤0.01% 3562
2024
Q1
$194K Buy
45,827
+3,000
+7% +$10.4K ﹤0.01% 3624
2023
Q4
$161K Buy
42,827
+5,800
+16% +$20K ﹤0.01% 3563
2023
Q3
$137K Buy
37,027
+200
+0.5% +$795 ﹤0.01% 3544
2023
Q2
$146K Buy
36,827
+2,000
+6% +$9.89K ﹤0.01% 3553
2023
Q1
$144K Buy
34,827
+1,200
+4% +$4.91K ﹤0.01% 3570
2022
Q4
$142K Hold
33,627
﹤0.01% 3553
2022
Q3
$95K Hold
33,627
﹤0.01% 3616
2022
Q2
$135K Hold
33,627
﹤0.01% 3616
2022
Q1
$184K Sell
33,627
-2,599
-7% -$11.9K ﹤0.01% 3692
2021
Q4
$165K Buy
36,226
+3,815
+12% +$18.9K ﹤0.01% 3759
2021
Q3
$151K Buy
32,411
+11,137
+52% +$64.9K ﹤0.01% 3736
2021
Q2
$146K Sell
21,274
-2,825
-12% -$22.5K ﹤0.01% 3761
2021
Q1
$241K Buy
24,099
+1,899
+9% +$20K ﹤0.01% 3496
2020
Q4
$165K Hold
22,200
﹤0.01% 3460
2020
Q3
$134K Buy
22,200
+12,087
+120% +$60.7K ﹤0.01% 3325
2020
Q2
$64K Sell
10,113
-340
-3% -$1.57K ﹤0.01% 3354
2020
Q1
$38K Buy
+10,453
New +$59K ﹤0.01% 3351

Other funds holding CRMD